Promis Neurosciences (PMN) Insider Trading & Ownership $0.42 +0.01 (+3.52%) As of 10:32 AM Eastern This is a fair market value price provided by Polygon.io. Learn more. Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Promis Neurosciences (NASDAQ:PMN) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.11%Number OfInsiders Buying(Last 12 Months)3Amount OfInsider Buying(Last 12 Months)$191.65KNumber OfInsiders Selling(Last 12 Months)0 Get PMN Insider Trade Alerts Want to know when executives and insiders are buying or selling Promis Neurosciences stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address PMN Insider Buying and Selling by Quarter Promis Neurosciences Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame Start Date End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails2/10/2025Neil CashmanInsiderBuy15,000$0.97$14,550.00 9/23/2024Madge K ShafmasterDirectorBuy70,000$1.28$89,600.00 9/20/2024Madge K ShafmasterDirectorBuy60,000$1.25$75,000.00 8/14/2024Patrick D KirwinDirectorBuy10,000$1.25$12,500.00 (Data available from 1/1/2013 forward) PMN Insider Trading Activity - Frequently Asked Questions Who is on Promis Neurosciences' Insider Roster? The list of insiders at Promis Neurosciences includes Madge K Shafmaster, Neil Cashman, and Patrick D Kirwin. Learn more on insiders at PMN. What percentage of Promis Neurosciences stock is owned by insiders? 6.11% of Promis Neurosciences stock is owned by insiders. Learn more on PMN's insider holdings. Which Promis Neurosciences insiders have been buying company stock? The following insiders have purchased PMN shares in the last 24 months: Madge K Shafmaster ($164,600.00), Neil Cashman ($14,550.00), and Patrick D Kirwin ($12,500.00). How much insider buying is happening at Promis Neurosciences? Insiders have purchased a total of 155,000 PMN shares in the last 24 months for a total of $191,650.00 bought. More Insider Trading Tools from MarketBeat Related Companies CLSD Insider Transactions ASRT Insider Transactions STRO Insider Transactions RPTX Insider Transactions ANRO Insider Transactions ANEB Insider Transactions CNTX Insider Transactions VTGN Insider Transactions IMMX Insider Transactions NRXP Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles Micron Insiders Sell But Investors Should Buy, Buy, BuyInsider Selling at NVIDIA Could Turn Into an Opportunity The Top Insider Sells From Q2: Buy, Sell, or Hold?3 Hot Trades for Insiders, But Are They Good Buys for Investors?Insiders Chase Income and Stability in American Tower—Here’s Why This page (NASDAQ:PMN) was last updated on 7/8/2025 by MarketBeat.com Staff From Our PartnersEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredYour Bank Account Is No Longer SafeWhat If Washington Declared That: YOUR Money ISN'T Actually Yours? Sounds insane, but that's exactly what ...Priority Gold | SponsoredF1 Engineering Powers This Electric Marine MotorThe future of marine propulsion has arrived - powered by F-1 grade engineering. In collaboration with McLar...The Tomorrow Investor | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredForget Nvidia, This “Ghost Town” Company Holds the Key to the AI BoomCold War Discovery Could Unlock $100 Trillion in Wealth Jeff recently traveled to an American ghost town to...Brownstone Research | SponsoredWhite House to reset Social Security?Elon Musk's parting DOGE gift looks set to shock America... A single announcement by July 22nd could soon b...Altimetry | SponsoredThis Signal Only Flashes Once Every 4 Years – And It Just TriggeredThis same signal has appeared twice before in the past 8 years — both times, it kicked off major moves in cryp...Crypto Swap Profits | SponsoredA grave, grave error.I thought what happened 25 years ago was a once- in-a-lifetime event… but how wrong I was. Because here we...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Promis Neurosciences Please log in to your account or sign up in order to add this asset to your watchlist. Share Promis Neurosciences With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
